GLIPR1 expression is reduced in multiple myeloma but is not a tumour suppressor in mice.

by Natasha Friend, Jacqueline E Noll, Khatora S Opperman, Kimberley C Clark, Krzysztof M Mrozik, Kate Vandyke, Duncan R Hewett, Andrew C W Zannettino
Published 2020-01-01

LCRF‐0006, a small molecule mimetic of the N‐cadherin antagonist peptide ADH‐1, synergistically increases multiple myeloma response to bortezomib

by Krzysztof M. Mrozik, Chee M. Cheong, Duncan R. Hewett, Jacqueline E. Noll, Khatora S. Opperman, Alaknanda Adwal, Darryl L. Russell, Orest W. Blaschuk, Kate Vandyke, Andrew C. W. Zannettino
Published 2020-06-01

Targeted Disruption of Bone Marrow Stromal Cell-Derived Gremlin1 Limits Multiple Myeloma Disease Progression In Vivo

by Kimberley C. Clark, Duncan R. Hewett, Vasilios Panagopoulos, Natalya Plakhova, Khatora S. Opperman, Alanah L. Bradey, Krzysztof M. Mrozik, Kate Vandyke, Siddhartha Mukherjee, Gareth C.G. Davies, Daniel L. Worthley, Andrew C.W. Zannettino
Published 2020-08-01